Translation Research in Oncology- US, INC (TRIO-US) — Los Angeles, California

Translation Research in Oncology- US, INC (TRIO-US) is a clinical research site located in Los Angeles, California, United States 90025.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Translation Research in Oncology- US, INC (TRIO-US) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: iO Resistant sqNSCLC.

Sponsors: Fortvita Biologics (USA)Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Translation Research in Oncology- US, INC (TRIO-US)?

Translation Research in Oncology- US, INC (TRIO-US) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Translation Research in Oncology- US, INC (TRIO-US) conducted?

Translation Research in Oncology- US, INC (TRIO-US) has 1 clinical trials on record, with 1 currently active. Their work covers iO Resistant sqNSCLC.

Is Translation Research in Oncology- US, INC (TRIO-US) accredited by Crixeo Health?

Translation Research in Oncology- US, INC (TRIO-US) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Translation Research in Oncology- US, INC (TRIO-US)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.